Mersana Therapeutics is now a part of Day One Biopharmaceuticals

For more information, visit: https://www.dayonebio.com/

Simultaneous Quantification of Total Antibody and Antibody-Conjugated Drug for XMT-1522 in Human Plasma Using Immunocapture-Liquid Chromatography/Mass Spectrometry

September 2019

Read More